Inhibiting VEGF signaling by a VEGFR-2 inhibitor or an anti-VEGF blocking antibody reduces the injury-induced angiogenesis in a rodent model of stroke (Shimotake et al., 2010). Here, VEGFA is linked to stroke disorder.